Wellington Shields Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,300
Closed -$366K – 313
2023
Q3
$366K Sell
2,300
-200
-8% -$32.7K 0.05% 170
2023
Q2
$354K Hold
2,500
– – 0.04% 178
2023
Q1
$421K Hold
2,500
– – 0.05% 162
2022
Q4
$423K Hold
2,500
– – 0.05% 161
2022
Q3
$468K Hold
2,500
– – 0.11% 146
2022
Q2
$406K Hold
2,500
– – 0.05% 169
2022
Q1
$470K Hold
2,500
– – 0.05% 179
2021
Q4
$662K Hold
2,500
– – 0.08% 177
2021
Q3
$722K Sell
2,500
-650
-21% -$167K 0.1% 150
2021
Q2
$629K Hold
3,150
– – 0.08% 185
2021
Q1
$612K Buy
3,150
+200
+7% +$41K 0.06% 186
2020
Q4
$565K Sell
2,950
-100
-3% -$18.2K 0.08% 167
2020
Q3
$450K Buy
+3,050
New +$436K 0.07% 158

Other funds holding RGEN

Wellington Shields Capital Management's RGEN Position: Q4 2023 in Review

Wellington Shields Capital Management sold out of Repligen (RGEN) in Q4 2023, closing a stake of 2,300 shares — an estimated $366K sold.

Wellington Shields Capital Management first reported a position in RGEN in Q3 2020 and held it in 13 quarters. The position peaked at $722K in Q3 2021. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Wellington Shields Capital Management reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Wellington Shields Capital Management sold 2,300 Repligen shares in Q4 2023, an estimated $366K.
  • Wellington Shields Capital Management first reported a position in Repligen in Q3 2020 and held it in 13 quarters.
  • Wellington Shields Capital Management's Repligen position peaked at $722K in Q3 2021.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Wellington Shields Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.